RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 166 filers reported holding RIGEL PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,281 | -16.1% | 18,779 | +0.2% | 0.00% | – |
| Q2 2023 | $24,168 | -4.5% | 18,735 | -2.3% | 0.00% | – |
| Q1 2023 | $25,307 | -13.1% | 19,172 | -1.3% | 0.00% | – |
| Q4 2022 | $29,129 | +26.6% | 19,419 | -0.0% | 0.00% | – |
| Q3 2022 | $23,000 | +9.5% | 19,427 | +3.0% | 0.00% | – |
| Q2 2022 | $21,000 | -53.3% | 18,853 | -0.1% | 0.00% | – |
| Q1 2022 | $45,000 | -11.8% | 18,866 | -1.5% | 0.00% | – |
| Q4 2021 | $51,000 | -29.2% | 19,155 | -2.9% | 0.00% | – |
| Q3 2021 | $72,000 | -18.2% | 19,733 | -3.2% | 0.00% | – |
| Q2 2021 | $88,000 | +17.3% | 20,378 | -6.6% | 0.00% | – |
| Q1 2021 | $75,000 | -3.8% | 21,825 | -2.4% | 0.00% | – |
| Q4 2020 | $78,000 | +52.9% | 22,364 | +5.4% | 0.00% | – |
| Q3 2020 | $51,000 | +24.4% | 21,215 | -5.3% | 0.00% | – |
| Q2 2020 | $41,000 | -43.1% | 22,391 | -51.5% | 0.00% | – |
| Q1 2020 | $72,000 | -25.8% | 46,136 | +2.1% | 0.00% | – |
| Q4 2019 | $97,000 | +125.6% | 45,175 | +94.9% | 0.00% | – |
| Q3 2019 | $43,000 | +104.8% | 23,181 | +185.4% | 0.00% | – |
| Q1 2019 | $21,000 | +10.5% | 8,121 | 0.0% | 0.00% | – |
| Q4 2018 | $19,000 | -26.9% | 8,121 | 0.0% | 0.00% | – |
| Q3 2018 | $26,000 | +30.0% | 8,121 | +15.1% | 0.00% | – |
| Q2 2018 | $20,000 | -20.0% | 7,053 | 0.0% | 0.00% | – |
| Q1 2018 | $25,000 | -44.4% | 7,053 | -39.5% | 0.00% | – |
| Q4 2017 | $45,000 | +50.0% | 11,653 | 0.0% | 0.00% | – |
| Q3 2017 | $30,000 | -6.2% | 11,653 | 0.0% | 0.00% | – |
| Q2 2017 | $32,000 | +39.1% | 11,653 | +66.8% | 0.00% | – |
| Q1 2017 | $23,000 | +35.3% | 6,986 | 0.0% | 0.00% | – |
| Q4 2016 | $17,000 | -29.2% | 6,986 | +5.9% | 0.00% | – |
| Q3 2016 | $24,000 | – | 6,599 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 1,500,000 | $1,620,000 | 1.72% |
| Soleus Capital Management, L.P. | 14,803,015 | $15,987,256 | 1.48% |
| ARMISTICE CAPITAL, LLC | 17,136,000 | $18,506,880 | 0.28% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,228,126 | $1,326,376 | 0.24% |
| GSA CAPITAL PARTNERS LLP | 971,441 | $1,049 | 0.09% |
| NJ State Employees Deferred Compensation Plan | 200,000 | $216,000 | 0.03% |
| Providence Wealth Advisors, LLC | 27,500 | $29,013 | 0.03% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 1,151,765 | $1,243,906 | 0.03% |
| XTX Topco Ltd | 164,238 | $177,377 | 0.03% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 3,369,076 | $3,638,602 | 0.02% |